← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3220)
- Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells. (2017/12/28) ♡
- Novel mutational landscapes and expression signatures of lung squamous cell carcinoma. (2017/12/27) ♡
- Effect of postoperative systemic therapy on pulmonary adenocarcinoma with unexpected pleural spread detected during thoracotomy or thoracoscopy. (2017/12/26) ♡
- The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages. (2017/12/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Newly developed anti-angiogenic therapy in non-small cell lung cancer. (2017/12/26) ♡
- Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. (2017/12/26) ♡
- Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis. (2017/12/23) ♡
- The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis. (2017/12/23) ♡
- The microtubule-associated protein PRC1 is a potential therapeutic target for lung cancer. (2017/12/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeted drugs for systemic therapy of lung cancer with brain metastases. (2017/12/22) ♡
- Apatinib as a third- or further- line treatment in patients with advanced NSCLC harboring wild-type EGFR. (2017/12/22) ♡
- Prognostic role of tumor-infiltrating CD57-positive lymphocytes in solid tumors: a meta-analysis. (2017/12/22) ♡
- High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer. (2017/12/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Implications of KRAS mutations in acquired resistance to treatment in NSCLC. (2017/12/21) ♡
- Anti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancer. (2017/12/21) ♡
- Clinicopathological characteristics and survival outcomes in adenosquamous carcinoma of the lung: a population-based study from the SEER database. (2017/12/21) ♡
- Incidence and risk of hepatic toxicities associated with anaplastic lymphoma kinase inhibitors in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis. (2017/12/16) ♡
- Co-expression analysis revealed PTCH1-3'UTR promoted cell migration and invasion by activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer: implicating the novel function of PTCH1. (2017/12/13) ♡
- PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression. (2017/12/08) ♡
- Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases. (2017/12/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Resolution of atelectasis during radiochemotherapy of lung cancer with serious implications for further treatment. A case report. (2017/12/08) ♡
- A Population-based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-small Cell Lung Cancer Patients. (2017/12/07) ♡
- [Role of PET/CT in primitive non-small cell bronchopulmonary cancer]. (2017/12/04) ♡
- Mistletoe (Viscum album) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells. (2017/12/01) ♡
- Seleno-short-chain chitosan induces apoptosis in human non-small-cell lung cancer A549 cells through ROS-mediated mitochondrial pathway. (2017/12/01) ♡
- Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition. (2017/12/01) ♡
- Exome-wide association study of plasma lipids in >300,000 individuals. (2017/12/01) ♡
- Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer. (2017/12/01) ♡
- Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer. (2017/12/01) ♡
- Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeted therapy of brain metastases: latest evidence and clinical implications. (2017/12/01) ♡
- Durvalumab for the treatment of urothelial carcinoma. (2017/12/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Knocking down MiR-15a expression promotes the occurrence and development and induces the EMT of NSCLC cells in vitro. (2017/12/01) ♡
- Combined C-reactive protein and Neutrophil to Lymphocyte ratio use predict survival in non-small-cell lung cancer. (2017/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment for non-small-cell lung cancer and circulating tumor cells. (2017/12/01) ♡
- A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy. (2017/11/29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study. (2017/11/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report. (2017/11/27) ♡
- Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage. (2017/11/27) ♡
- Barriers to non-small cell lung cancer trial eligibility. (2017/11/24) ♡
- Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS). (2017/11/24) ♡
- Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells. (2017/11/18) ♡
- Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells. (2017/11/15) ♡
- Involvement of autophagy in the outcome of mitotic catastrophe. (2017/11/06) ♡
- Anticancer Effects of a Korean Herbal Medicine Formula (H9) via AMPK and HER2-PI3K/Akt Signaling in Breast Cancer Cells. (2017/11/01) ♡
- Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non-Small Cell Lung Carcinoma. (2017/11/01) ♡
- Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. (2017/11/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study. (2017/11/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.